Rheum palmatum L. Attenuates High Fat Diet-Induced Hepatosteatosis by Activating AMP-Activated Protein Kinase
Authors:
- 1 January 2016
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 44 (03) , 551-564
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common metabolic disorder characterized by the accumulation of excess fat in the liver. Rheum palmatumL. (RP) decoctions have been reported to ameliorate NAFLD. The aim of the present study was to investigate the effects and underlying mechanisms of RP in fatty liver disease induced by a high-fat diet (HFD) in rats. Low and high doses of aqueous RP extraction were orally administered to HFD-fed rats for six weeks. Body weight, tissue weight, glucose tolerance, insulin tolerance, hepatic morphology, and liver triglyceride (TG) content were assessed. The effects of RP on the expressions of lipogenic and lipolysis genes were measured by quantitative real-time PCR. The phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) was determined by Western blotting. Treatment with low-dose RP significantly reduced liver weight, liver TG content, and improved glucose tolerance in HFD-fed rats. Consistently, RP attenuated excess fat accumulation and downregulated the expression of lipogenic genes in the liver. Further, an increased phosphorylation of AMPK and ACC was observed. These findings suggest that low-dose RP alleviates hepatosteatosis, at least in part, by stimulating AMPK activity.Keywords
This publication has 31 references indexed in Scilit:
- Potential Antineoplastic Effects of Aloe-emodin: A Comprehensive ReviewThe American Journal of Chinese Medicine, 2014
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivoEuropean Journal of Pharmacology, 2010
- Epidemiology and Natural History of Non-Alcoholic SteatohepatitisClinics in Liver Disease, 2009
- New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)Annals of Medicine, 2009
- Treatment of non-alcoholic fatty liver diseasePostgraduate Medical Journal, 2006
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004
- Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 DiabetesDiabetes, 2003
- Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2002
- Assessment of Insulin Sensitivityin Vivo*Endocrine Reviews, 1985